BR112012018458A2 - métodos e composições para diagnóstico pré-natal não invasivo de aneuploidias fetais - Google Patents

métodos e composições para diagnóstico pré-natal não invasivo de aneuploidias fetais

Info

Publication number
BR112012018458A2
BR112012018458A2 BR112012018458A BR112012018458A BR112012018458A2 BR 112012018458 A2 BR112012018458 A2 BR 112012018458A2 BR 112012018458 A BR112012018458 A BR 112012018458A BR 112012018458 A BR112012018458 A BR 112012018458A BR 112012018458 A2 BR112012018458 A2 BR 112012018458A2
Authority
BR
Brazil
Prior art keywords
dna
fetal
methods
compositions
hypomethylated
Prior art date
Application number
BR112012018458A
Other languages
English (en)
Portuguese (pt)
Inventor
A Papageorgiou Elisavet
C Patsalis Philippos
Original Assignee
Nipd Genetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipd Genetics Ltd filed Critical Nipd Genetics Ltd
Publication of BR112012018458A2 publication Critical patent/BR112012018458A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BR112012018458A 2010-01-26 2011-01-26 métodos e composições para diagnóstico pré-natal não invasivo de aneuploidias fetais BR112012018458A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29833910P 2010-01-26 2010-01-26
US40542110P 2010-10-21 2010-10-21
PCT/IB2011/000217 WO2011092592A2 (en) 2010-01-26 2011-01-26 Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies

Publications (1)

Publication Number Publication Date
BR112012018458A2 true BR112012018458A2 (pt) 2018-07-10

Family

ID=44278821

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012018458A BR112012018458A2 (pt) 2010-01-26 2011-01-26 métodos e composições para diagnóstico pré-natal não invasivo de aneuploidias fetais

Country Status (17)

Country Link
US (1) US9249462B2 (enExample)
EP (1) EP2529032B1 (enExample)
JP (1) JP2013517789A (enExample)
KR (1) KR20120107512A (enExample)
CN (1) CN102892899A (enExample)
AU (1) AU2011210255B2 (enExample)
BR (1) BR112012018458A2 (enExample)
CA (1) CA2786174A1 (enExample)
CY (1) CY1118864T1 (enExample)
DK (1) DK2529032T3 (enExample)
EA (1) EA023565B1 (enExample)
ES (1) ES2623156T3 (enExample)
NZ (1) NZ601079A (enExample)
PL (1) PL2529032T3 (enExample)
PT (1) PT2529032T (enExample)
SG (1) SG182322A1 (enExample)
WO (1) WO2011092592A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
EP2516680B1 (en) 2009-12-22 2016-04-06 Sequenom, Inc. Processes and kits for identifying aneuploidy
US9605313B2 (en) 2012-03-02 2017-03-28 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2872648B1 (en) 2012-07-13 2019-09-04 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
FI4056712T3 (fi) * 2012-09-20 2024-08-29 Univ Hong Kong Chinese Kasvaimen metyloomin nonivasiivinen määrittäminen plasmasta
CN104838013A (zh) * 2012-09-26 2015-08-12 新加坡科技研究局 用于唐氏综合症产前诊断的生物标志物
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
KR20140118682A (ko) 2013-03-29 2014-10-08 (주)셀트리온 2 이상의 인플루엔자 a 바이러스 중화 결합 분자를 포함하는 조성물
EP3117011B1 (en) 2014-03-13 2020-05-06 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
RU2583830C2 (ru) * 2014-04-21 2016-05-10 Закрытое акционерное общество "Геноаналитика" Способ неинвазивной пренатальной диагностики анеуплоидий плода
EP2942401A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Detection of DNA that originates from a specific cell-type
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
EP3521454A1 (en) 2014-05-09 2019-08-07 LifeCodexx AG Detection of dna that originates from a specific cell-type and related methods
US20180187267A1 (en) * 2017-01-05 2018-07-05 Michael J. Powell Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence
US10174383B2 (en) * 2014-08-13 2019-01-08 Vanadis Diagnostics Method of estimating the amount of a methylated locus in a sample
WO2016176846A1 (zh) * 2015-05-06 2016-11-10 安诺优达基因科技(北京)有限公司 检测染色体非整倍性的试剂盒、装置和方法
WO2016189388A1 (en) 2015-05-22 2016-12-01 Nipd Genetics Ltd Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
DK3168309T3 (da) 2015-11-10 2020-06-22 Eurofins Lifecodexx Gmbh Detektion af føtale kromosomale aneuploidier under anvendelse af dna-regioner med forskellig metylering mellem fosteret og det gravide hunkøn
SG11201804651XA (en) * 2015-12-04 2018-07-30 Green Cross Genome Corp Method for determining copy-number variation in sample comprising mixture of nucleic acids
KR101817180B1 (ko) * 2016-01-20 2018-01-10 이원다이애그노믹스(주) 염색체 이상 판단 방법
US10781490B2 (en) 2016-05-30 2020-09-22 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free DNA in blood
CN109112209B (zh) * 2017-06-25 2022-06-24 国家卫生计生委科学技术研究所 用于无创产前检测胎儿非整倍体染色体的参考品
US12027237B2 (en) 2018-03-13 2024-07-02 Grail, Llc Anomalous fragment detection and classification
KR20200060969A (ko) 2018-11-23 2020-06-02 (주)셀트리온 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법
US12234514B2 (en) 2018-12-21 2025-02-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free DNA samples
US20230151409A1 (en) * 2020-03-30 2023-05-18 Vilnius University Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites
KR102332540B1 (ko) * 2020-07-02 2021-11-29 의료법인 성광의료재단 다운증후군 특이적인 후성학적 마커를 이용한 다운증후군 진단 방법
US20250079015A1 (en) * 2022-01-10 2025-03-06 Washington State University Dna methylation biomarkers for preterm birth
WO2024216205A1 (en) * 2023-04-14 2024-10-17 Adela, Inc. Methods and systems for cell-free nucleic acid processing
WO2025179073A1 (en) * 2024-02-21 2025-08-28 Adela, Inc. Methods and systems for tissue informed differentially methylated region analysis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
JP5013869B2 (ja) * 2003-09-22 2012-08-29 トリソゲン バイオテクノロジー リミテッド パートナーシップ 遺伝子座コピー数の変化を検出するのに有用な方法およびキット
US20050282213A1 (en) 2003-09-22 2005-12-22 Trisogen Biotechnology Limited Partnership Methods and kits useful for detecting an alteration in a locus copy number
GB0413688D0 (en) 2004-06-18 2004-07-21 Novartis Forschungsstiftung Analysis of methylated nucleic acid
AU2005308918B2 (en) 2004-11-29 2012-09-27 Sequenom, Inc. Means and methods for detecting methylated DNA
WO2007044780A2 (en) 2005-10-07 2007-04-19 Emory University Methods and systems for screening for and diagnosing dna methylation associated abnormalities and sex chromosome aneuploidies
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
EP3892736A1 (en) 2007-07-23 2021-10-13 The Chinese University of Hong Kong Determining a nucleic acid sequence imbalance
JP5322471B2 (ja) 2008-03-27 2013-10-23 シスメックス株式会社 メチル化dnaの解析方法及びプライマーセット
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses

Also Published As

Publication number Publication date
KR20120107512A (ko) 2012-10-02
WO2011092592A3 (en) 2011-11-03
CN102892899A (zh) 2013-01-23
PL2529032T3 (pl) 2017-07-31
US9249462B2 (en) 2016-02-02
CA2786174A1 (en) 2011-08-04
NZ601079A (en) 2014-08-29
US20120282613A1 (en) 2012-11-08
PT2529032T (pt) 2017-05-04
SG182322A1 (en) 2012-08-30
ES2623156T3 (es) 2017-07-10
JP2013517789A (ja) 2013-05-20
WO2011092592A2 (en) 2011-08-04
EA201290716A1 (ru) 2013-06-28
AU2011210255A1 (en) 2012-07-26
EP2529032B1 (en) 2017-01-25
AU2011210255B2 (en) 2014-11-20
EA023565B1 (ru) 2016-06-30
CY1118864T1 (el) 2018-01-10
EP2529032A2 (en) 2012-12-05
DK2529032T3 (en) 2017-05-01

Similar Documents

Publication Publication Date Title
BR112012018458A2 (pt) métodos e composições para diagnóstico pré-natal não invasivo de aneuploidias fetais
CY1124139T1 (el) Μη επεμβατικος προσδιορισμος μεθυλωματος ογκου απο πλασμα
BR112018008532A2 (pt) detecção de aneuploidias cromossômicas do feto usando regiões de dna que são metiladas de forma diferenciada entre o feto e a mulher grávida
EA202190075A2 (ru) Анализ транскриптома материнской плазмы с применением массивного параллельного секвенирования рнк
BR112015024110A2 (pt) método de detecção de um distúrbio de gravidez ou aneuploidia fetal até o segundo trimestre
IN2012DN03139A (enExample)
BR112014026661A2 (pt) método in vitro para diagnóstico e vigilância do câncer
MY205940A (en) Gestational age assessment by methylation and size profiling of maternal plasma dna
WO2014165267A3 (en) Systems and methods for prenatal genetic analysis
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
BR112013030152A2 (pt) método implantado por computador que habilita um formato de apresentação para um bloco de aplicativo
HUE043574T2 (hu) Magzati genomiális elemzés anyai biológiai mintából
BR112017011172A2 (pt) atenuação de interferência para sinais de referência de posicionamento
BR112015022821A2 (pt) método para avaliar status renal em um indivíduo e kit de ensaio de diagnóstico
DK3301193T3 (da) Størrelsesbaseret analyse af føtal dna-fraktion i maternelt plasma
BR112015007184A2 (pt) combinação de anticorpos anti-kir e anticorpos anti-pd-1 para tratar câncer
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
WO2011143659A3 (en) Nucleic acid isolation methods
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
BR112013006683A2 (pt) diagnóstico de câncer de mama
BR112015027937A2 (pt) método e sistema para avaliação de uma condição de saúde
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
BR112017016880A2 (pt) métodos de avaliação genômica em gado

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2480 DE 17-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.